IRME · IR-Med, Inc. · Short Interest
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2025, and as of the date of this report, we assessed our financial condition and concluded that based on our current and projected cash resources and commitments, as well as other factors mentioned above, there is a substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2025
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
IRME Latest Reported Short Interest
FINRA reported 15,889 IRME shares sold short as of the September 15, 2025 settlement date, an increase of 15,770 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent splits of this listing
Options positioning & squeeze sensitivity
Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.
A complete options reference is unavailable.
Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.
Assessment prepared 2026-10-22 01:20 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.
| Settlement Date | Current Position | Previous Position | Change | Days to Cover | |
|---|---|---|---|---|---|
|
2026-10-30
Scheduled
FINRA publishes Nov 10
|
— | — | — | — | |
|
2026-10-15
Scheduled
FINRA publishes Oct 26
|
— | — | — | — | |
| No short interest data in the selected range. | |||||
Full FINRA short interest reporting calendar